Dosidal · Switzerland

Galvus, Tabletten

Dosidal is a product record. It identifies a medicine and its regulatory status. It does not advise on use.

MarketSwitzerland
Recordch:authorisation:57834 (version 1)
Levelauthorisation
Pack codenot anchored
Identifiersswissmedic-authorisation: 57834
atc: A10BH02
Source authoritySwissmedic
Read date
authorisation statusfirst_authorisation: 2008-04-30
term: zugelassen
valid_until: 9999-12-31
state: current · read 2026-11-15T01:25:13Z · source: Swissmedic (OGD) page
identityatc: A10BH02
authorisation_number: 57834
form: TAB
holder: Novartis Pharma Schweiz AG
holder_partner_nr: 1006575
it_number: 07.06.2.
name: Galvus, Tabletten
state: current · read 2026-11-15T01:25:13Z · source: Swissmedic (OGD) page
SignatureES256 over JCS, key dosidal-record-1.9dbf5d53
JtE0XK88K6pD40QFPbm4T7oFa5khzey6mC_Qpirt6DWn-Zev4NlTDxM2fLNFURZvmzDMnO3fCvMfc6Iy6va2jQ
Verify with verify_record (MCP) or POST https://dosidal-api.ai/v1/verify/record; keyring https://dosidal-registry.ai/.well-known/jwks.json

JSON: https://dosidal-api.ai/v1/records/ch:authorisation:57834 · Same medicine in other markets · Dosidal